Your browser doesn't support javascript.
loading
Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1.
Monteillier, Aymeric; Loucif, Alexandre; Omoto, Kiyoyuki; Stevens, Edward B; Lainez, Sergio; Saintot, Pierre-Philippe; Cao, Lishuang; Pryde, David C.
Afiliação
  • Monteillier A; Pfizer Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridge CB21 6GS, UK.
  • Loucif A; Pfizer Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridge CB21 6GS, UK.
  • Omoto K; Worldwide Medicinal Chemistry, Pfizer Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridge CB21 6GS, UK.
  • Stevens EB; Pfizer Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridge CB21 6GS, UK.
  • Lainez S; Pfizer Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridge CB21 6GS, UK.
  • Saintot PP; Pfizer Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridge CB21 6GS, UK.
  • Cao L; Pfizer Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridge CB21 6GS, UK.
  • Pryde DC; Worldwide Medicinal Chemistry, Pfizer Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridge CB21 6GS, UK. Electronic address: david@curadev.co.uk.
Bioorg Med Chem Lett ; 26(20): 4919-4924, 2016 10 15.
Article em En | MEDLINE | ID: mdl-27641472
ABSTRACT
TRESK (Twik RElated Spinal cord K+ channel) is a member of the Twin Pore Domain potassium channel (K2P) family responsible for regulating neuronal excitability in dorsal root ganglion (DRG) and trigeminal (TG) neurons, peripheral neurons involved in pain transmission. As channel opening causes an outward K+ current responsible for cell hyperpolarisation, TRESK represents a potentially interesting target for pain treatment. However, as no crystal structure exists for this protein, the mechanisms involved in the opening action of its ligands are still poorly understood, making the development of new potent and selective openers challenging. In this work we present a structure activity relationship (SAR) of the known TRESK opener flufenamic acid (FFA) and some derivatives, investigating the functional effects of chemical modifications to build a TRESK homology model to support the biological results. A plausible binding mode is proposed, providing the first predictive hypothesis of a human TRESK opener binding site.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Canais de Potássio / Ácido Flufenâmico Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Bioorg Med Chem Lett Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Canais de Potássio / Ácido Flufenâmico Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Bioorg Med Chem Lett Ano de publicação: 2016 Tipo de documento: Article